Who is affected by this change?

This affects Independence Blue Cross Dermatology providers on Medicare Advantage plans.

When does this change take effect?

This change is effective Mar 4, 2026.

Back to dashboard

Medicare AdvantageAdministrativeLow impact

MA07.002i, Ultraviolet Light Therapy for the Treatment of Dermatological Conditions

Independence Blue Cross·Dermatology·Medical Policy

Effective date

Mar 4, 2026

We identified it

Jun 19, 2026

Days to comply

—

Summary

The Medicare Advantage policy MA07.002i for Ultraviolet Light Therapy for the Treatment of Dermatological Conditions has been reissued. This appears to be a routine policy update rather than a substantive change to coverage or billing requirements.

Action Required

Action needed

By March 4, 2026: Billing team should review the updated policy MA07.002i for any changes to ultraviolet light therapy coverage requirements for Medicare Advantage plans. Access the full policy details at the provided URL to identify any modifications to billing procedures or documentation requirements.

Related policy hubs

Independence Blue Cross policies Dermatology